Regeneron Pharmaceuticals Long-Term Investments 2010-2024 | REGN
Regeneron Pharmaceuticals long-term investments for the quarter ending September 30, 2024 were $8.491B, a 46.94% increase year-over-year.
- Regeneron Pharmaceuticals long-term investments for 2023 were $5.397B, a 18.13% decline from 2022.
- Regeneron Pharmaceuticals long-term investments for 2022 were $6.592B, a 3.6% decline from 2021.
- Regeneron Pharmaceuticals long-term investments for 2021 were $6.838B, a 118.08% increase from 2020.